Cargando…

Characteristics of patients potentially eligible for pharmacotherapy for weight loss in primary care practice in the United States

OBJECTIVE: To describe the characteristics of real‐world patients potentially eligible for adjunctive pharmacotherapy for weight loss. METHODS: Patients from the GE Centricity electronic medical record database were selected if they had body mass index (BMI) ≥30 or ≥27 to <30 kg m(−2) with ≥1 obe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shumin, Manne, Sudhakar, Lin, Jennifer, Yang, Jiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089644/ https://www.ncbi.nlm.nih.gov/pubmed/27840686 http://dx.doi.org/10.1002/osp4.46

Ejemplares similares

FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade
por: Idrees, Zarwa, et al.
Publicado: (2022)

U Can't Touch This With Pharmacotherapy Alone for Weight Loss or Smoking Cessation
por: Curtiss, Frederic R.
Publicado: (2005)

An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal
por: Enright, Connor, et al.
Publicado: (2023)

Patient Eligibility for Transoral Endocrine Surgery Procedures in the United States
por: Grogan, Raymon H., et al.
Publicado: (2019)

Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss
por: Liberini, Claudia G., et al.
Publicado: (2019)

Long‐term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study
por: Tchang, Beverly G., et al.
Publicado: (2021)

The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery
por: Colbourne, James R. M., et al.
Publicado: (2023)

Sponsorship of oncology clinical trials in the United States according to age of eligibility
por: Neel, Dylan V., et al.
Publicado: (2020)

Estimating the Number of Patients Eligible for Carbon Ion Radiotherapy in the United States
por: Malouff, Timothy D., et al.
Publicado: (2020)

Supplemental Nutrition Assistance Program Eligibility and HIV Incidence in the United States
por: Richterman, Aaron, et al.
Publicado: (2021)

Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom
por: Liang, Huifang, et al.
Publicado: (2017)

Weight Loss Challenges in Achieving Transplant Eligibility in Patients With Kidney Failure: A Qualitative Study
por: Freeman, Johanne, et al.
Publicado: (2021)

NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2020)

Weight Considerations in Pharmacotherapy for Type 2 Diabetes
por: Cheng, Vicky, et al.
Publicado: (2011)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
por: Hammond, Michael M., et al.
Publicado: (2023)

Potential pharmacotherapy for Zinner syndrome
por: Takeshima, Teppei
Publicado: (2023)

Pediatric urology: Development, eligibility, practice
por: Bajpai, M.
Publicado: (2009)

Contemporary National Patterns of Eligibility and Use of Novel Lipid‐Lowering Therapies in the United States
por: Shen, Miles, et al.
Publicado: (2022)

Outcomes after ischemic stroke for dual-eligible Medicare-Medicaid beneficiaries in the United States
por: Leifheit, Erica C., et al.
Publicado: (2023)

Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response?
por: Paszkowiak, Maria, et al.
Publicado: (2023)

Trends in Self-perceived Weight Status, Weight Loss Attempts, and Weight Loss Strategies Among Adults in the United States, 1999-2006
por: Han, Liyuan, et al.
Publicado: (2019)

OR10-3 Long-term Weight Loss Maintenance with Obesity Pharmacotherapy: a 5-Year Retrospective Study
por: Andre, Clarissa, et al.
Publicado: (2022)

High Burden of Obesity and Low Rates of Weight Loss Pharmacotherapy in Inflammatory Bowel Disease: 10-Year Trend
por: Elangovan, Abbinaya, et al.
Publicado: (2023)

Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom
por: Ye, Yizhou, et al.
Publicado: (2021)

A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States
por: Harris, Linda, et al.
Publicado: (2021)

Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States
por: Lozier, Jessica W., et al.
Publicado: (2021)

Disparities in effective contraceptive use in the United States among individuals dually eligible for Medicare and Medicaid
por: Rodriguez, Maria I., et al.
Publicado: (2023)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
por: Nag, Arpita, et al.
Publicado: (2020)

Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019
por: Kern, David M., et al.
Publicado: (2020)

The Rationale for Potential Pharmacotherapy of COVID-19
por: Saber-Ayad, Maha, et al.
Publicado: (2020)

Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy
por: Singh, Shamsher, et al.
Publicado: (2014)

Practical outpatient pharmacotherapy for alcohol use disorder
por: Kim, Youngjung, et al.
Publicado: (2018)

Beneficial effects of training at the anaerobic threshold in addition to pharmacotherapy on weight loss, body composition, and exercise performance in women with obesity
por: Ozcelik, Oguz, et al.
Publicado: (2015)

Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy
por: Merlino, Dante J., et al.
Publicado: (2014)

Clinical Characteristics, Risk Factors for Severity and Pharmacotherapy in Hospitalized COVID-19 Patients in the United Arab Emirates
por: Almarashda, Amna Mohamed Juma, et al.
Publicado: (2022)

Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
por: Prodduturi, Prathima, et al.
Publicado: (2012)

Pharmacotherapy for Depression and Anxiety in the Primary Care Setting
por: Parish, Abby Luck, et al.
Publicado: (2023)

Estimating the Burden of Chagas Disease in the United States
por: Manne-Goehler, Jennifer, et al.
Publicado: (2016)

Weight Loss Interventions for Hispanic Women in the United States: A Systematic Review
por: Morrill, Kristin E., et al.
Publicado: (2021)

Novel method versus the Friedewald method for estimating low-density lipoprotein cholesterol in determination of the eligibility for statin treatment for primary prevention in the United States
por: Shin, Doosup, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1v1sscaee80bs3ibn21n94573r